Capitalmind AMC prefers pharma over banks, sees pressure on consumption sectors
Anoop Vijaykumar, Head of Equities at Capitalmind AMC, says pharma remains one of the most attractive sectors due to healthy earnings growth, reasonable valuations and…
Anoop Vijaykumar, Head of Equities at Capitalmind AMC, says pharma remains one of the most attractive sectors due to healthy earnings growth, reasonable valuations and…

Indian equities snapped a two-session losing streak on Tuesday, with banking stocks leading the recovery after fresh RBI measures to attract foreign currency inflows. Strong…

Pradeep Choudhary, CEO of Gemini Edibles and Fats India, believes the edible oil market could remain in a supportive price environment over the coming months,…

Persistent foreign investor selling has pushed valuations of leading private lenders to attractive levels, creating a potential opportunity for long-term investors, according to Motilal Oswal…

Nandan Kulkarni, Director–India Healthcare & Senior Research Analyst at Bernstein, sees strong opportunities in CDMOs, specialty therapies, biosimilars and licensing deals. While favouring Zydus, Lupin…

TCS now accounts for just 32.5% of Tata Group’s valuation, down from nearly 75% in 2020, as AI concerns, weak IT spending and geopolitical tensions…

Mehli Mistry challenges non renewal as Sir Ratan Tata Trust trustee, alleges governance lapses, conflicts of interest, and seeks Charity Commissioner scrutiny and an independent…

Defence Minister Rajnath Singh has approved a 250 MW solar power project with battery storage on vacant defence land in Uttar Pradesh, marking the Ministry…

The Mumbai-based developer said it sold over 1,000 homes with a total area exceeding 1.8 million square feet during the launch week of the project,…

According to Bernstein, valuations across the Indian biopharma sector have re-rated significantly, with the Nifty Pharma index trading slightly above its 10-year average multiple of…